LETTERS TO THE EDITOR
|Year : 2022 | Volume
| Issue : 3 | Page : 511
Cerebral Malaria, COVID-19 and complete blood examination
Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2
1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India
|Date of Submission||21-Sep-2021|
|Date of Acceptance||24-Sep-2021|
|Date of Web Publication||13-Jan-2022|
Private Academic Consultant, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Mungmunpuntipantip R, Wiwanitkit V. Cerebral Malaria, COVID-19 and complete blood examination. Ann Indian Acad Neurol 2022;25:511
We read the report by Ram et al. with great interest. Ram et al. reported on the co-occurrence of COVID-19 and malaria and concluded that “Every suspected case of COVID encephalitis has to be investigated for all possible causes …….” In the present report, it is likely that there is a problem in the first complete blood count examination. In laboratory medicine, a blood smear examination should be routinely done, and it is usually neglected when an automated hematology analyzer is widely used. Because the incubation period for COVID-19 (14 days) and cerebral malaria (12 days) can overlap, it is no doubt that there might be a co-infection and a disease might be underdiagnosed. Also, it is possible that malaria might be a recurrence, not a newly acquired infection, and co-manifest with COVID-19. When hydroxychloroquine is used for the management of COVID-19, it might also manage malaria co-infection in some cases and co-infection might be finally underdiagnosed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ram A, Padmanabhan S, Warrier AR, Wilson A. Cerebral malaria in a patient with COVID-19. Ann Indian Acad Neurol 2021;24:616-7. [Full text]
Sardar S, Sharma R, Alyamani TYM, Aboukamar M. COVID-19 and plasmodium vivax malaria co-infection. IDCases 2020;21:e00879.
Pusparani A, Henrina J, Cahyadi A. Co-infection of COVID-19 and recurrent malaria. J Infect Dev Ctries 2021;15:625-9.